Skip to main content

Table 3 Angiographic features

From: The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study

 

SGLT2i (n = 22)

Control (n = 20)

p-value

Location of lesions

   

 LMCA

0

1

0.28

 LAD

12

14

0.08

 LCx

11

4

0.043

 RCA

5

7

0.10

 VG

0

1

0.28

Bifurcation lesion

14

7

0.054

Stent diameter (mm)

40 ± 23

61 ± 30

0.551

Number of stents placed

28

27

0.20

SYNTAX score

16.60 ± 7

14.05 ± 9

0.11

Contrast medium volume (mL)

144 ± 66

176 ± 54

0.23

Procedural time (min)

60 ± 30

77 ± 40

0.46

ACC/AHA Lesion classification

A-5

A-2

0.08

B1–6

B1–6

B2–5

B2–9

C-6

C-4

  1. ACC, American College of Cardiology; AHA, American Heart Association; LMCA, left main coronary artery; LAD, left anterior descending artery; LCx, left circumflex artery; RCA, right coronary artery; VG, vein graft. T student was used to compare means between groups